CVE-2006-2390
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject...
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject arbitrary web script or HTML via the vname parameter in the comments functionality.
Exploit likelihood
What each source reports
NVD Score used
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject arbitrary web script or HTML via the vname parameter in the comments functionality.
- Record
CVE-2006-2390- CVSS 2.0
- 5.8 Medium
AV:N/AC:M/Au:N/C:P/I:P/A:N - Updated
- 2026-11-02
CVE List No score
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject arbitrary web script or HTML via the vname parameter in the comments functionality.
- Record
CVE-2006-2390- Updated
- 2026-11-02
EUVDEUVD-2006-2391 No score
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject arbitrary web script or HTML via the vname parameter in the comments functionality.
- Record
EUVD-2006-2391- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-w2hj-cfm6-8q54 No score
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject...
Cross-site scripting (XSS) vulnerability in OZJournals 1.2 allows remote attackers to inject arbitrary web script or HTML via the vname parameter in the comments functionality.
- Record
GHSA-w2hj-cfm6-8q54- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| Exploit-DB | OZJournals 1.2 - 'Vname' Cross-Site Scripting | 2006-05-12 |
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, Exploit-DB, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2006-2390 is a medium vulnerability (CVSS 5.8) in Ozjournals, published May 16, 2006. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 1.81%, the 78th percentile. No source names a fixed version.